MedVi vs Gala: Compounded Semaglutide Plans Compared
MedVi vs Gala: both are direct-pay telehealth platforms for compounded GLP-1 care, but they differ on pricing structure, medication options, clinician access, shipping speed, and how compounded drugs are presented. Early verdict: if you want the cheapest promotional first month and 24/7 certified medical support, MedVi stands out; if you want access to both semaglutide and tirzepatide with one flat price and provider check-ins, Gala is the clearer choice.
How pricing and promotions compare
MedVi advertises a winter promotional first month starting at $179 including fast, free shipping, then notes a standalone month rises to $299 with a three-month plan at $649. Gala shows a promotional $220 off and advertises a flat all-inclusive price covering provider visit, medication, shipping, and ongoing care, but the base dollar price was not exposed in readable page text.
Medication options and formulation
MedVi focuses on clinically dosed compounded semaglutide only; the source states MedVi offers semaglutide only and no tirzepatide option. Gala explicitly offers both compounded semaglutide and tirzepatide as options on its platform.
Care model and clinician access
Both platforms operate fully online with no required in-office visits. MedVi emphasizes a simple online intake with a licensed clinician review and 24/7 support from certified medical professionals. Gala highlights provider visit and prescription included along with provider check-ins and dose monitoring.
Shipping, membership, and cancellation
MedVi advertises fast, free shipping included in the promotional price and emphasizes no membership or hidden fees on landing content. Gala states free two-day shipping, no monthly membership, and cancel anytime; Gala also claims one flat price at every dose and no hidden fees.
Comparison at a glance
| Criteria | MedVi | Gala |
|---|---|---|
| Starting price | Promotional first month starting at $179 with free shipping | Advertises $220 off; base price not visible in readable text |
| Medication options | Compounded semaglutide only | Compounded semaglutide and tirzepatide offered |
| Pricing model | Promotional first month, higher ongoing month ($299) or three-month plan at $649 | One flat all-inclusive price claimed at every dose; provider visit included |
| Clinician support | Licensed clinician review plus 24/7 certified medical support | Provider visit, check-ins, and dose monitoring included |
| Shipping | Fast, free shipping included in promo | Free two-day shipping stated |
| Regulatory note | Compounded medications are not FDA-approved and not reviewed by FDA | Compounded medications are not FDA-approved and not reviewed by FDA |
Evidence-based differences that matter
1) Upfront cost shape: MedVi uses a promotional low first month then higher ongoing pricing; Gala emphasizes a single flat all-inclusive price with a visible promotional discount but does not expose the base price in readable text. 2) Drug choices: MedVi offers semaglutide only; Gala offers both semaglutide and tirzepatide. 3) Support model: MedVi markets 24/7 certified medical support and a no-clinic process; Gala promotes included provider visits, check-ins, and dose monitoring.
Practical implications for patients
If your priority is an inexpensive promotional entry and around-the-clock certified medical support with a clear stated first-month price, MedVi provides that pathway with a $179 first-month promo and clinician review online. If you want the option to be prescribed tirzepatide as well as semaglutide and prefer a single flat price that claims to stay the same at every dose, Gala presents that option but does not show a readable base price on the page captured.
Safety and regulatory notes to weigh
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. MedVi also states compounded medications are produced in FDA-regulated facilities but are not FDA-approved. MedVi notes that OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s and that results vary and may be affected by adherence and clinician recommendations. Gala content warns that compounded medications are not FDA-approved.
Choose MedVi if…
you prioritize a promotional first-month price advertised as $179 with fast, free shipping and 24/7 certified medical support, and you only want compounded semaglutide delivered via a no-clinic online process.
Choose Gala if…
you want the option of both compounded semaglutide and tirzepatide, prefer a single flat all-inclusive price with provider visit and ongoing check-ins included, and value free two-day shipping and cancel-anytime membership terms.